Plasma Lipid Profile Reveals Plasmalogens as Potential Biomarkers for Colon Cancer Screening

In this era of precision medicine, there is an increasingly urgent need for highly sensitive tests for detecting tumors such as colon cancer (CC), a silent disease where the first symptoms may take 10–15 years to appear. Mass spectrometry-based lipidomics is an emerging tool for such clinical diagno...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Metabolites
Главные авторы: Fernandes, Anna Maria A.P., Messias, Marcia C.F., Duarte, Gustavo H.B., de Santis, Gabrielle K.D., Mecatti, Giovana C., Porcari, Andreia M., Murgu, Michael, Simionato, Ana Valéria C., Rocha, Thalita, Martinez, Carlos A.R., Carvalho, Patricia O.
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7345851/
https://ncbi.nlm.nih.gov/pubmed/32630389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo10060262
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы